Pharmaceutical Executive
May 20, 2016
Features
36
5
Pharm Exec’s 10th annual Brand of the Year is Bristol-Myers Squibb’s Opdivo, which has raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers-melanoma, lung, and renal.
May 18, 2016
Features
36
5
A conversation with GlaxoSmithKline's US Pharmaceuticals head Jack Bailey.
May 05, 2016
Features
36
5
An “how to” primer for life sciences companies on applying end-to-end evidence strategies in demonstrating product value.
May 04, 2016
From the Editor
36
5
The Boston biotech cluster proved an ideal setting for Pharm Exec's recent annual Editorial Advisory Board meeting, with the prevailing message that even the best environments for innovation require constant nurturing.
May 01, 2016
Columns
36
5
Policymakers seek to limit prescribing while also encouraging innovative R&D.
May 01, 2016
Special Sponsored Section
36
5
while France remains a global force in the pharmaceutical, medical device, and vaccines fields-and continues to tout a solid manufacturing base and re-exportation culture-questions are arising over the long- term sustainability of the country’s healthcare system and its traditionally generous public health provisions.
May 01, 2016
Issue PDF
36
5
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
April 27, 2016
Column
36
5
Policymakers seek to limit prescribing while also encouraging innovative R&D.